Skip to main content

European Medicines Agency

Question for Department of Health

UIN 116840, tabled on 30 November 2017

To ask the Secretary of State for Health, what his policy is on the UK's relationaship with the European Medicines Agency after the UK leaves the EU.

Answered on

5 December 2017

We recognise the important role that the European Medicines Agency plays in the protection of human and animal health.

In the negotiations the Government will discuss with the European Union and Member States how best to continue cooperation in the field of medicines regulation in the best interests of both the United Kingdom and the EU.

The UK is fully committed to continuing the close working relationship with our European partners. Our aim is to ensure that patients in the UK and across the EU continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data. As the Prime Minister has stated, we want deep, broad and dynamic co-operation and in this context, the UK would like to find a way to continue to collaborate with the EU, in the interests of public health and safety.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.